Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging

Topics in Magnetic Resonance Imaging

Volumn 10, Issue 2, 1999, Pages 130-142

  Parker, Geoffrey J M ^a   Tofts, Paul S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Contrast agents; Magnetic resonance imaging; Permeability; Pharmacokinetic modeling

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ARTICLE; CANCER DIAGNOSIS; CAPILLARY PERMEABILITY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG PENETRATION; HUMAN; INTERSTITIUM; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0032711751     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-199904000-00006     Document Type: Article

References (96)

1. Folkman J. Angiogenesis in cancer, vasculature, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
3. Jain RK. Barriers to drug delivery in solid tumours. Sci Am 1994;July:42-49.
4. Folkman J. Tumour angiogenesis and tissue factor. Nat Med 1996; 2:167-168.
5. Mitchell DG. MR imaging contrast agents - What's in a name? J Magn Reson Imaging 1997;7:1-4.
6. Kaiser WA, Zeitler E. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA. Radiology 1989;170:681-686.
7. Erlemann R, Reiser MF, Peters PE, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 1989;171:767-773.
8. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain lesions. Magn Reson Med 1990;16:117-131.
9. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
10. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomgr 1991;15:621-628.
11. Tofts PS, Berkowitz BA, Schnall M. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. Magn Reson Med 1995;33:564-568.
12. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
13. Parker GJM, Suckling J, Tanner SF, et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997;7:564-574.
14. Roberts TPL. Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations. J Magn Reson Imaging 1997; 7:82-90.
15. Buckley DL, Kerslake RW, Blackband SJ, Horsman A. Quantitative analysis of multi-slice Gd-DTPA enhanced MR images using an automated simplex minimisation procedure. Magn Reson Med 1994; 32:646-651.
16. Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch R. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique. Magn Reson Med 1993;29:616-622.
17. Ohtomo K, Itai Y, Yoshikawa K, et al. Hepatic tumors: Dynamic MR imaging. Radiology 1987;163:27-31.
18. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: Tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990;174:491-494.
19. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging 1993;11:617-620.
20. Gilles R, Guinebretiere J-M, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: Preliminary results in 26 patients. Radiology 1993;188:473-478.
21. Gilles R, Guinebretiere J-M, Lucidarme O, et al. Nonpalpable breast tumours: Diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994;191:625-631.
22. Gribbestad IS, Nilsen G, Fjrsne HE, et al. Contrast-enhanced magnetic resonance imaging of the breast. Acta Oncol 1992;31:833-842.
23. Gribbestad IS, Nilsen G, Fjrsne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 1994;4:477-480.
24. Turkat TJ, Klein BD, Polan RL, Richman RH. Dynamic MR mammography: A technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 1994;4:563-568.
25. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995;197:387-395.
26. Barentsz JO, Jager GJ, van Vierzen PBJ, et al. Staging urinary bladder cancer after transurethral biopsy: Value of fast dynamic contrast-enhanced MR imaging. Radiology 1996;210:185-193.
27. Ichikawa T, Ohtomo K, Ichiyama G, Fujimoto H, Nasu K. Contrast-enhanced dynamic MRI of adrenal masses: Classification of characteristic enhancement patterns. Clin Radiol 1995;50:295-300.
28. Bonnerot V, Charoentier A, Frouin F, Kalifa C, Vanael D, Di Paola R. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 1992;27:847-855.
29. Verstraete KL, Dierick A, De Deene Y, et al. First-pass of musculoskeletal lesions: A new and useful diagnostic application of dynamic contrast-enhanced MRI. Magn Reson Imag 1994;12:687-702.
30. Lang P, Honda G, Roberts T, et al. Musculoskeletal neoplasm: Perineoplastic edema versus tumor dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 1995;197:831-839.
31. Padhani AR, Gapinsky CJ, James F, et al. Dynamic MR enhancement in prostate cancer: Correlation with morphology and MRI stage, histological grade and serum PSA. Radiology 1997;205(SS): 43.
32. Parker GJM, Suckling J, Tanner SF, Padhani AR, Husband JE, Leach MO. MRIW: Parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. RadioGraphics 1998;18: 497-506.
33. Joo YG, Korogi Y, Hirai T, et al. Differential diagnosis of extra-axial intracranial tumours by dynamic spin-echo MRI. Neuroradiology 1995;37:522-525.
34. Mäurer J, Rausch M, Richter WS, et al. Dynamic MRI of tumours in head and neck with a contrast-enhanced FLASH-2D sequence. Eur Radiol 1995;5:504-510.
35. Reinges MHT, Kaiser WA, Miersch WD, Vogel J, Reiser M, Dynamic MRI of benign and malignant testicular lesions: Preliminary observations. Eur Radiol 1995;5:615-622.
36. Ito K, Choji T, Nakada T, Nakanishi T, Kurokawa F, Okita K. Multislice dynamic MRI of hepatic tumors. J Comput Assist Tomogr 1993;17:390-396.
37. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997;3:780-782.
38. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 1996;6:743-752.
39. Jain RK. The next frontier of molecular medicine: Delivery of therapeutics. Nat Med 1998;4:655-657.
40. Aime S, Nano R. Factors determining the proton T1 relaxivity in solutions containing Gd-DTPA. Invest Radiol 1988;23:S264-S266.
41. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
42. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951;3:1-41.
43. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959;197:1205-1210.
44. Crone C. The permeability of capillaries in various organs as determined by the indicator diffusion method. Acta Physiol Scand 1963; 58:292-305.
45. Johnson JA, Wilson TA. A model for capillary exchange. Am J Physiol 1966;210:1299-1303.
46. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metabol 1983;3:1-7.
47. Iannotti F, Fieschi C, Alfano B, et al. Simplified, noninvasive PET measurement of blood-brain barrier permeability. J Comput Assist Tomogr 1987;11:390-397.
48. Webb S, Ott RJ, Cherry SR. Quantitation of blood-brain barrier permeability by positron emission tomography. Phys Med Biol 1989;34:1767-1771.
49. Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ. Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 1991;11:1356-1361.
50. Wilson CBJH, Lammertsma AA, McKenzie CG, Sikora K, Jones T. Measurements of blood flow and exchanging water space in breast tumours using positron emission tomography: A rapid and noninvasive dynamic method. Cancer Res 1992;52:1592-1597.
51. Tofts PS, Kermode AG. Measurement of blood brain permeability using Gd-DTPA scanning. Magn Reson Imaging 1989;7:150.
52. Tofts PS, Kermode AG. Blood brain permeability measured in multiple sclerosis using labelled DTPA with PET. CT and MRI. J Neurol Neurosurg Psychiatry 1989;52:1019-1020.
53. Tofts PS, Kermode AG, Barker G. Measurement of the blood-brain permeability using dynamic Gd-DTPA scanning. In: Proceedings of 8th Annual Meeting of the Society of Magnetic Resonance in Medicine. Amsterdam: Society of Magnetic Resonance in Medicine 1989:805.
54. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect using MRI and gadolinium-DTPA in acute multiple sclerosis. In: Proceedings of the 8th Annual Meeting of the Society of Magnetic Resonance in Medicine. Amsterdam: Society of Magnetic Resonance in Medicine 1989:744.
55. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Parameterization of the MRI signal enhancement during and after i.v. infusion of Gd-DTPA: A pharmacokinetic model. In: Proceedings of the 9th Annual Meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine 1990:758.
56. Kermode AG, Tofts PS. Non-invasive measurement of human blood-brain barrier transfer constant using dynamic magnetic resonance imaging. J Physiol 1990;423:42P.
57. Tofts PS, Berkowitz BA. Rapid measurement of capillary permeability using the early part of the dynamic Gd-DTPA MRI enhancement curve. J Magn Reson 1993;102:129-136.
58. Tofts PS, Berkowitz BA. Measurement of capillary permeability from the Gd enhancement curve: A comparison of bolus and constant infusion methods. Magn Reson Imaging 1994;12:81-91.
59. Furman-Haran E, Margalit R, Maretzek AF, Degani H. Angiogenic response of MCF7 human breast cancer to hormonal treatment: assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution. J Magn Reson Imaging 1996;6:195-202.
60. Hoffman U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: A new method for dynamic MR mammography. Magn Reson Med 1995;33:506-514.
61. Su M, Jao J, Nalcioglu O. Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med 1994;32:714-724.
62. Gowland P, Mansfield P, Bullock P, Stehling M, Worthington B, Firth J. Dynamic studies of gadolinium uptake in brain tumours using inversion recovery echo-planar imaging. Magn Reson Med 1992;26:241-258.
63. Müller-Schimpfle M, Ohmenhausaer K, Sand J, Stoll P, Claussen CD. Dynamic 3D-MR mammography: Is there a benefit of sophisticated evaluation of enhancement curves for clinical routine? J Magn Reson Imaging 1997;7:236-240.
64. Mussurakis S, Buckley DL, Drew PJ, et al. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours. Clin Radiol 1997;52:516-526.
65. Hunter GJ, Hamberg LM, Choi N, Jain RK, McCloud T, Fischman AJ. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: Correlating vascular physiology with glucose metabolism. Clin Cancer Res 1998;4:949-955.
66. Larsson HBW, Tofts PS. Measurement of blood brain barrier permeability using dynamic Gd-DTPA scanning - A comparison of methods. Magn Reson Med 1992;24:174-176.
67. Parker GJM, Tanner SF, Leach MO. Pitfalls in the measurement of tissue permeability over short time-scales using multi-compartment models with a low temporal resolution blood input function. In: Proceedings of the 4th Meeting of the International Society of Magnetic Resonance in Medicine. New York: International Society of Magnetic Resonance in Medicine 1996:1582.
68. Mussurakis S, Buckley DL, Horsman A. Dynamic MRI of invasive breast cancer: Assessment of three region-of-interest analysis methods. J Comput Assist Tomogr 1997;21:431-438.
69. Larsson HBW, Stubgaard M, Sondergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. J Magn Reson Imaging 1994;4:433-440.
70. Fritz-Hansen T, Rostrup E, Larsson HBW, Sondergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: A step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225-231.
71. Larsson HBW, Fritz-Hansen T, Rostrup E, Sondergaard L, Ring P, Henriksen O. Myocardial perfusion modeling using MRI. Magn Reson Med 1996;35:716-726.
72. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: Differentiation with echo-planar MR imaging. Radiology 1995;197:33-38.
73. Henderson E, Rutt BK, Lee T-Y. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 1998;16:1057-1073.
74. Tofts PS. Optimal detection of blood-brain barrier defects with Gd-DTPA MRI - the influences of delayed imaging and optimised repetition time. Magn Reson Imaging 1996;14:373-380.
75. Edmister WB, Weisskoff RM. Optimal time resolution for dynamic breast imaging. In: Proceedings of the 6th Meeting of the International Society of Magnetic Resonance in Medicine. Sydney: International Society of Magnetic Resonance in Medicine, 1998:228.
76. Buckley DL, Mussurakis S, Horsman A. Effect of temporal resolution on the diagnostic efficacy of contrast-enhanced MRI in the conservatively treated breast. J Comput Assist Tomogr 1998;22:47-51.
77. Parker GJM. Monitoring contrast agent kinetics using dynamic MRI: Quantitative and qualitative analysis. PhD thesis, University of London, London, 1997.
78. Bluml S, Schad LR, Stepanow B, Lorenz WJ. Spin-lattice relaxation time measurement by means of a turboFLASH technique. Magn Reson Med 1993;30:289-295.
79. Parker GJM, Tanner SF, Leach MO. Raw data filter to reduce blurring in a turboFLASH images acquired with centric-ordered k-space - modelling and application. In: Proceedings of the 5th Meeting of the International Society of Magnetic Resonance in Medicine. Vancouver: International Society of Magnetic Resonance in Medicine 1997:2009.
80. Parker GJM, Barker GJ, Tofts PS. Accurate multislice T1 measurement in the presence of non-ideal RF pulse profiles and RF field inhomogeneity. In: Proceedings of the 7th Meeting of the International Society for Magnetic Resonance in Medicine. Philadelphia: International Society for Magnetic Resonance in Medicine, 1999:2144.
81. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994; 31:567-571.
82. Brookes JA, Redpath TW, Gilbert FJ, Needham G, Murray AD. Measurement of spin-lattice relaxation times with FLASH for dynamic MRI of the breast. Brit J Radiol 1996;69:206-214.
83. Demsar F, Roberts TPL, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-242.
84. Blomqvist L, Fransson P, Hindmarsh T. The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging. Eur Radiol 1998;8:781-787.
85. Rieber A, Zeitler H, Rosenthal H, et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 1997;70:452-458.
86. Padhani AR, Parker GJM, Tanner SF, et al. Evaluation of the response of breast carcinoma to chemotherapy using dynamic MR mammography: Preliminary observations. In: Proceedings of the 4th Meeting of the International Society of Magnetic Resonance in Medicine. New York: International Society of Magnetic Resonance in Medicine, 1996:764.
87. Padhani AR, Gapinsky C, Revell PB, et al. Effect of hormonal treatment on prostate morphology, tumour detection and tumour vascular permeability. In: Proceedings of the 7th Meeting of the International Society of Magnetic Resonance in Medicine. Sydney: International Society of Magnetic Resonance in Medicine, 1998:486.
88. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imag 1997;7:68-74.
89. Van Dijke CF, Brasch RC, Roberts TPL, et al. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198:813-818.
90. Roberts HC, Saeed M, Roberts TPL, et al. Comparison of albumin-(Gd-DTPA) (30) and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability. J Magn Reson Imaging 1997;7:331-338.
91. Su MY, Muhler A, Lao XY, Nalcioglu O. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med 1998;39:259-269.
92. Buckley DL, Drew PJ, Mussurakis S, Monson JRT, Horsman A. Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 1997;7:461-464.
93. Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: Characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997;57: 4777-4786.
94. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 1998;28:67-78.
95. Leach MO. Assessing contrast enhanced MRI as a method of screening women at genetic risk of breast cancer: Study design, methodology and analysis. In: Proceedings of the 6th Meeting of the International Society of Magnetic Resonance in Medicine. Sydney: International Society of Magnetic Resonance in Medicine, 1998:226.
96. Hawighorst H, Knapstein PG, Knopp MV. et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 1998;58:3598-3602.